These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10471427)

  • 41. Increased cerebral perfusion following reduction of fibrinogen and lipid fractions.
    Walzl B; Walzl M; Valetitsch H; Lechner H
    Haemostasis; 1995; 25(3):137-43. PubMed ID: 7607582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption.
    Drouin-Chartier JP; Tremblay AJ; Bergeron J; Lamarche B; Couture P
    Atherosclerosis; 2018 Mar; 270():26-32. PubMed ID: 29407885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentrations and the course of coronary heart disease. The HELP-Study Group. Heparin-induced extra-corporeal LDL-precipitation.
    Schuff-Werner P; Gohlke H; Bartmann U; Baggio G; Corti MC; Dinsenbacher A; Eisenhauer T; Grützmacher P; Keller C; Kettner U
    Eur J Clin Invest; 1994 Nov; 24(11):724-32. PubMed ID: 7890009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Changes of blood lipids in colorectal cancer patients with coronary heart disease and value of lipid-lowering therapy with statins].
    Liang ZT; Wang XP; Zeng QT; Liao YH; Gao CY; Li MW
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):863-5. PubMed ID: 18504222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impaired brachial artery endothelial function is not predicted by elevated triglycerides.
    Schnell GB; Robertson A; Houston D; Malley L; Anderson TJ
    J Am Coll Cardiol; 1999 Jun; 33(7):2038-43. PubMed ID: 10362211
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study).
    Cantin B; Després JP; Lamarche B; Moorjani S; Lupien PJ; Bogaty P; Bergeron J; Dagenais GR
    Am J Cardiol; 2002 Mar; 89(6):662-6. PubMed ID: 11897206
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective removal of plasma low density lipoprotein with the HELP system: biweekly versus weekly therapy.
    Lane DM; McConathy WJ; Laughlin LO; Comp PC; von Albertini B; Bricker LA; Kozlovskis P; Lees RS; Dorrier C
    Atherosclerosis; 1995 Apr; 114(2):203-11. PubMed ID: 7605389
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.
    Ezhov MV; Safarova MS; Afanasieva OI; Pogorelova OA; Tripoten MI; Adamova IY; Konovalov GA; Balakhonova TV; Pokrovsky SN
    Atheroscler Suppl; 2015 May; 18():163-9. PubMed ID: 25936321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method.
    Hirano T; Ito Y; Koba S; Toyoda M; Ikejiri A; Saegusa H; Yamazaki J; Yoshino G
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):558-63. PubMed ID: 14726414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipoprotein(a), other lipoproteins and hemostatic profiles in patients with ischemic stroke: the relation to cardiogenic embolism.
    Dahl T; Kontny F; Slagsvold CE; Christophersen B; Abildgaard U; Odegaard OR; Morkrid L; Dale J
    Cerebrovasc Dis; 2000; 10(2):110-7. PubMed ID: 10686449
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Lipoprotein(a): Aspects of pathophysiology, epidemiology and treatment].
    Thomas HP; Steinhagen-Thiessen E
    Z Kardiol; 2003; 92(Suppl 3):III53-8. PubMed ID: 14663603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sex dependency of cerebrovascular CO2 reactivity in normal subjects.
    Kastrup A; Thomas C; Hartmann C; Schabet M
    Stroke; 1997 Dec; 28(12):2353-6. PubMed ID: 9412613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of plasma lipid peroxidation during LDL-apheresis by heparin-induced extracorporeal LDL-precipitation.
    Wieland E; Schettler V; Creutzfeldt C; Kickbusch H; Schuff-Werner P
    Eur J Clin Invest; 1995 Nov; 25(11):838-42. PubMed ID: 8582449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease.
    Jürgens G; Taddei-Peters WC; Költringer P; Petek W; Chen Q; Greilberger J; Macomber PF; Butman BT; Stead AG; Ransom JH
    Stroke; 1995 Oct; 26(10):1841-8. PubMed ID: 7570736
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP).
    Schuff-Werner P; Schütz E; Seyde WC; Eisenhauer T; Janning G; Armstrong VW; Seidel D
    Eur J Clin Invest; 1989 Feb; 19(1):30-7. PubMed ID: 2499459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of a single HELP application on hemorheology and retinal hemodynamics.
    Haas A; Walzl M; Eckhardt M; Walzl B; Faulborn J; Feigl B
    Ophthalmologica; 1996; 210(3):171-4. PubMed ID: 8738463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benefits of lipid lowering on vascular reactivity in patients with coronary artery disease and average cholesterol levels: a mechanism for reducing clinical events?
    Cohen JD; Drury JH; Ostdiek J; Finn J; Babu BR; Flaker G; Belew K; Donohue T; Labovitz A
    Am Heart J; 2000 Apr; 139(4):734-8. PubMed ID: 10740160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How to optimize lipoprotein apheresis treatment--a second look.
    Schettler V; Neumann CL; Hagenah GC; Schulz EG; Wieland E
    Atheroscler Suppl; 2013 Jan; 14(1):89-92. PubMed ID: 23357148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heparin-Induced extracorporeal low-density lipoprotein precipitation apheresis: a new therapeutic concept in the treatment of sudden hearing loss.
    Suckfüll M
    Ther Apher; 2001 Oct; 5(5):377-83. PubMed ID: 11778923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.